References
- Grosu A, Senni M, Iacovoni A et al. Cardiac Resynchronization in Combination with β blocker Treatment in Advanced Chronic Heart Failure (CARIBE-HF): the results of the CARIBE-HF study. Acta Cardiol.66(5), 573–580 (2011).
- McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N. Engl. J. Med.285, 1441–1446 (1971).
- Roger VL, Go AS, Lloyd-Jones DM et al. Heart disease and stroke statistics – 2011 update: a report from the American Heart Association. Circulation123(4), e18–e209 (2011).
- Farwell D, Patel NR, Hall A, Ralph S, Sulke AN. How many people with heart failure are appropriate for biventricular resynchronization? Eur. Heart J.21(15), 1246–1250 (2000).
- Baldasseroni S, Opasich C, Gorini M et al. Left bundle branch block is associated with increased 1-year sudden death and mortality rate in 5517 outpatients with congestive heart failure. Am. Heart J.143, 398–405 (2002).
- Gras D, Leclercq C, Tang A, Bucknall C, Luttikhuis HO, Kirstein-Pedersen A. Effects of abnormal activation on the time course of the left ventricular pressure pulse in dilated cardiomyopathy. Br. Heart J.68, 403–407 (1992).
- Bruch C, Stypmann J, Grude M, Gradaus R, Breithardt G, Wichter T. Left bundle branch block in chronic heart failure – impact on diastolic function, filling pressures, and B-type natriuretic peptide levels. J. Am. Soc. Echocardiogr.19(1), 95–101 (2006).
- Xiao HB, Lee CH, Gibson DG. Effect of left bundle branch block on diastolic function in dilated cardiomyopathy. Br. Heart J.66, 443–447 (1991).
- Rouleau JL, Roecker EB, Tendera M et al. Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvediolol Prospective Randomized Cumulative Survival (COPERNICUS) study. J. Am. Coll. Cardiol.43(8), 1423–1429 (2004).
- Mehta PA, McDonagh S, Poole-Wilson PA, Grocott-Mason R, Dubrey SW. Heart failure in a district general hospital: are target doses of β-blockers realistic? Q. J. Med.97(3), 133–139 (2004).
- Shamim W, Yousufuddin M, Cicoria M, Gibson DG, Coats AJ, Henein MY. Incremental changes in QRS duration in serial ECGs over time identify high risk elderly patients with heart failure. Heart88, 47–51 (2002).
- Bristow R, Gilbert EM, Abraham WT et al. For the MOCHA investigators. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation94, 2807–2816 (1996).
- Voigt A, Shalaby A, Adelstein E, Saba S. β-blocker utilization and outcomes in patients receiving cardiac resynchronization therapy. Clin. Cardiol.33(7), e1–e5 (2010).
- Cleland JG, Daubert J, Erdmann E et al. For the cardiac resynchronization – heart failure (CARE-HF) study investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N. Engl. J. Med.352, 1539–1549 (2005).
- McAlister F, Stewart S, Ferrua S, McMurray J. Multidisciplinary strategies for the management of heart failure patients at high risk for admission. J. Am. Coll. Cardiol.44, 810–819 (2004).